Objective Many studies have revealed that white blood cell count (WBC) is related to insulin resistance which is a central mechanism of metabolic syndrome (MetS). However, few cohort studies have examined the role of WBC in the development of MetS. We hypothesized that WBC is associated with the future development of MetS, and investigated the longitudinal incidence of MetS in healthy workers. Methods WBC was measured in 5,073 workers (mean age 42.5 years) without MetS at baseline. The incidence of MetS was monitored over 7 years of follow-up, in relation to quartiles of WBC. During the followup, 925 participants were diagnosed as MetS. Results Incidence of MetS was increased in participants with higher WBC: the rates of incidence of MetS were 22.6, 32.9, 42.9, and 57.5 per 1,000 person-years of follow-up in the 1st, 2nd, 3rd, and 4th quartiles of WBC, respectively. After adjustments for confounding factors, the adjusted hazards ratio (95% confidence interval) for MetS was 1.00 (reference), 1.22 (0.98 to 1.51), 1.52 (1.24 to 1.87), and 1.66 (1.35 to 2.04) through the quartiles of WBC, respectively, (p <0.001). This relationship was consistent among current smokers and never smokers, and among male and female genders, respectively. Conclusion WBC is useful in predicting the future development of MetS which leads to atherosclerotic diseases.
Introduction
White blood cell count (WBC) is an objective marker of systemic inflammation. An elevated WBC has been associated with cigarette smoking, obesity, and low physical activity (1) (2) (3) . In contrast, the healthy practices such as maintaining normal weight and current non-smoking are negatively associated with WBC, and cultivating healthier practices would lead to lower WBC, or the prevention of low-grade inflammation (4) . Evidence from many epidemiological studies implicate WBC as an independent risk marker for coronary heart disease, stroke, heart failure and all-cause mortality and suggest that leukocytes may be important in the development and progression of atherosclerosis (5) (6) (7) (8) (9) .
Metabolic syndrome (MetS) is also defined by a condition of high risk for cardiovascular disease (10) . Previous studies showed significant associations of WBC with insulin resistance which is a central mechanism of MetS (11) . From the viewpoint of primary and secondary prevention of MetS, which leads to the development of atherosclerotic disease, it is important to examine the associations between WBC and the incidence of MetS. Many previous studies have shown cross-sectional associations between WBC and MetS (12) (13) (14) (15) (16) . However, a cross-sectional relationship alone is not sufficient to prove a causal relation. Thus, we hypothesized that WBC is associated with the longitudinal incidence of MetS. We tested this hypothesis by investigating the 7-year incidence of MetS in participants who did not have MetS at baseline.
Participants and Methods

Study design and participants
We designed a retrospective cohort study to investigate the relation between WBC and the incidence of new MetS in employees in general health checkup at YAHAMA Health Care Center, Hamamatsu, Japan. Most of the participants were employees of manufacturing companies in Hamamatsu, Japan. The center at which the checkups were performed currently evaluates more than 6,500 examinees annually. The Industrial Safety and Health Law in Japan requires the employer to conduct annual health examinations of all employees. The participants were followed up subsequently by a general health check-up every year. Because many participants were expected to have repeated examinations, we took advantage of this opportunity to conduct a follow-up study on MetS. The ethics committee of YAMAHA Health Insurance Society approved this study.
Data collection and measurements
After an overnight fast, blood samples were obtained to measure blood levels of routine medical checkup tests: glucose (FPG), triglyceride (TG), high-density lipoprotein cholesterol (HDL-c), total cholesterol (TC), hemoglobin A1c (HbA1c), uric acid (UA), blood cell counts, liver and kidney function tests including gamma glutamyltransferase (GGT), asparate aminotransferase (AST), alanine aminotransferase (ALT) and creatinine (Crt). Simple qualitative urinalyses were performed with dipstick. Chemical measurements were all performed at the local laboratory. A systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured with the participants in a sitting position. The height and body weight were measured with the participants wearing lightweight clothing. The participants were all required to fill out a self-administered questionnaire including queries about lifestyle factors and medical history, including smoking status (never, former or current smoker), alcohol drinking habit (nondrinker or drinker), regular exercise habit (>20 minutes per week) and antihypertensive, antidiabetic and antidyslipidemic medications. Three health practices including smoking status, alcohol intake and regular exercise were selected as study variables from self-administered questionnaires. A body mass index (BMI) was calculated as weight in kilogram divided by the square of height in meters. Estimated glomerular filtration rate (eGFR) was calculated as eGFR (mL/min/1.73 m 2 ) =194× Crt -1.094 × age -0.287 in men, and 194× creatinine -1.094 × age -0.287 × 0.739 in women according to the Japanese Society of Nephrology. Chronic kidney disease (CKD) was defined from eGFR of <60 mL/min/1.73 m 2 or dipstick proteinuria (!1+). Hypercholesterolemia was defined as total cholesterol !220 mg/dL. High age was defined as age !40 years old.
Criteria for metabolic syndrome
The diagnosis of MetS was made by the modified criteria of the American Heart Association and National Heart, Lung, and Blood Institute recommendation of MetS (17) . As in some other previous studies, we used BMI as a surrogate for waist circumference because data on this parameter were not available in this study sample (18, 19) . The five thresholds used were: (1) TG levels !150 mg/dL (!1.70 mmol/ L); (2) HDL-c levels < 40 mg/dL (<1.04 mmol/L) in men or < 50 mg/dL (<1.30 mmol/L) in women; (3) FPG !100 mg/ dL (!5.55 mol/L) or taking an antidiabetic medication; (4) SBP !130 mmHg or DBP !85 mmHg or taking an antihypertensive medication; and (5) BMI !25 kg/m 2 . A BMI of 25 kg/m 2 or grater has been proposed as a cutoff for the diagnosis of increased BMI in Asian people (20) . These five parameters were designated 'metabolic components' in the current study, and MetS was diagnosed when three or more metabolic components were present.
Follow-up and end point
The participants were followed from the starting point until December 31, 2009 . As in this study, the primary endpoint of this analysis was an incidence of new MetS. Study participation was considered to be complete for any individual participant at the time he or she had an occurrence of the primary endpoint, was unable to be followed further because of loss of follow-up, or had been followed through at least December 31, 2009. The exposure time was calculated as the time between the first visit to our institution and incidence of new MetS, the date of the last study visit, whichever came first.
Statistical analysis
All of the data were expressed as the mean ± standard deviation (SD) (parametrically distributed values) or median (interquartile range) (non-parametrically distributed values) of the indicated numbers. We divided the study population into gender-adjusted quartiles of the distribution of WBC. Differences among the quartiles of WBC were examined by one-way analyses of variance (ANOVA). Categorical variables were compared among the quartiles of WBC by chisquare test. Polynomial contrast test and Kendall tau rank correlation coefficient (Kendall's tau-b) was used for trend analysis of numerical and categorical variables. Multivariate logistic regression analysis was used to assess the contribution of each health practice to WBC. Cox proportionalhazards models were used to calculate hazard ratios and 95% confidence intervals for the comparison of event rates while controlling for potential cofounders. The potential cofounders were selected from clinical variables and lifestyle factors which were different between participants with and without MetS in a total study sample before we excluded the participants with MetS at baseline. A p value of less than 0.05 was regarded as denoting a statistically significant difference. The computations were performed using SPSS 
Results
Between January 2002 and December 2002, we invited the 6,671 participants (5,210 men and 1,461 women) in the general health checkup to enroll in the study. We excluded 684 participants who were diagnosed as MetS (n=676), lacked some laboratory data (n=6) and had missing data for health practices (n=2) at baseline. In addition, we excluded the participants who were not followed up at 2003 (n=914). Finally, the current analysis was restricted to 5,073 participants (3,946 men and 1,132 women) with complete data on all the health practices and general health checkup. Among those participants, 2,623 were lost to follow-up within the follow-up period. The mean follow-up period was 4.8 ± 2.8 year (range, 0.52 to 7.7), 24,175.3 person-years. Table 1 shows the participants' baseline demographic and clinical characteristics stratified by quartiles of WBC. There were significant associations between WBC and body weight, BMI, SBP, DBP, ALT, AST, GGT, TG, HDL-c, FPG, HbA1c, UA, red blood cell count (RBC), hematocrit (Hct), hemoglobin (Hb) and platelet counts (Plt), but there was no relationship of WBC with TC, Crt, eGFR and age. Furthermore, significant positive trend for quartiles of WBC were found in body weight, BMI, SBP, DBP, AST, TG, FPG, HbA1c, UA, RBC, Hct, Hb and Plt, while a significant negative trend was shown in HDL-c (all p <0.001 with polynomial contrast test). The proportions of high age, hypercholesterolemia and CKD were not associated with WBC. Table 2 shows that the proportion of participants who met each metabolic component. Significant positive trends for quartiles of WBC were found in all five metabolic components. Dose-response relationships between quartiles of WBC and the proportion of increased BMI, elevated blood pressure, elevated TG level and decreased HDL-c level were shown, while a dose-response relationship between quartiles of WBC and proportion of increased FPG level was not so clear. Fig. 1 shows the association between quartiles of WBC and the health practices. As shown in Fig. 1(A) , smoking habit was significantly related with the quartiles of WBC. The current smoking was independently associated with higher WBC, whereas the former smoking was correlated with lower WBC. The proportion of current smokers was 18.4%, 24.7%, 32.8% and 49.9%, respectively (p <0.001 with chi-square test), and of former smokers was 16.3%, HDL-cholesterol ; high density lipoprotein-cholesterol 14.3%, 12.2% and 7.8%, respectively (p <0.001 with chisquare test) through the quartiles of WBC. Alcohol drinking habit was also correlated with lower WBC. The proportion of drinkers was 60.6%, 54.6%, 53.1% and 54.5%, respectively, through the quartiles of WBC, (p <0.001 with chisquare test) ( Fig. 1(B) . The significant trends for the quartiles of WBC were found in those health practices (all p < 0.001 with Kendall's tau-b test).
Association between WBC and health practices
Incidence of metabolic syndrome in relation to quartiles of WBC
During the follow-up periods, a total of 925 participants received a new diagnosis of MetS, and 147, 195, 269 and 314 diagnoses were received in Q1, Q2 ,Q3 and the highest quartile of WBC (Q4). The overall incidence of MetS was 38.3 per 1,000 person-years. A graded relationship existed between WBC and incidence of MetS. The rates of incidence of MetS were 22.6, 32.9, 42.9 and 57.5 per 1,000 person-years of follow-up in Q1, Q2, Q3 and Q4, respectively (Fig. 2) .
In unadjusted analysis, the risk of MetS continuously rose with each increasing quartile of WBC. Compared with Q1, the hazards ratio of MetS among Q2, Q3 and Q4 were 1.44 [95% confidence interval (CI), 1.16 to 1.79], 1.88 (95% CI, 1.54 to 2.30) and 2.51 (95% CI, 2.06 to 3.05), respectively (Table 3 and Fig. 3) . In a test for interaction between the quartiles of WBC and follow-up time, there was no violation of the proportional-hazards assumption. In multivariable analyses using Cox proportional hazards models, the significant graded association between WBC and incidence of MetS persisted after adjustment for gender, high age, hypercholesterolemia, smoking status, alcohol drinking habit, CKD and numbers of metabolic components at baseline. The number of metabolic components was included as a covariate to determine whether the relationship between the quartiles of WBC and MetS. Compared with Q1, the adjusted hazards ratios of MetS among Q2, Q3 and Q4 were 1.22 (95 % CI, 0.98 to 1.51), 1.53 (95 % CI, 1.25 to 1.87) and 1.67 (95% CI, 1.36 to 2.05), respectively (Table 3 ). 
Smoking status and incidence of metabolic syndrome in relation to quartiles of WBC
We next investigated the association among various types of smoking status, WBC and incidence of MetS. WBC in never, former, and current smokers were 5.7 ± 1.4×10 9 cells/L, 5.7 ± 1.3×10 9 cells/L, and 6.8 ± 1.8×10 9 cells/L (p < 0.001 with ANOVA), respectively. Logistic regression analysis showed that the odds ratios of former and current smoking for Q4 was 0.94 (95% CI, 0.73 to 1.20) and 3.42 (95% CI, 2.92 to 4.01), respectively, after adjusting for gender, high age, hypercholesterolemia, alcohol drinking habit and CKD. The incidences of MetS in never, former and current smoker were 30.1, 50.1 and 49.0 per 1000 person-years, respectively. After subdivision according to the smoking status, the quartile of WBC was an independent predictor for MetS after adjusting for gender, high age, hypercholesterolemia, alcohol drinking habit, CKD and numbers of metabolic components in never and current smokers, whereas it was not statistically significant in former smokers (Table 4) .
Gender difference of incidence of metabolic syndrome in relation to quartiles of WBC
We finally investigated the association among gender, WBC and incidence of MetS. Table 5 showed the incidence of MetS in each gender. After subdivision according to the gender, the quartile of WBC was an independent predictor for MetS after adjusting for high age, hypercholesterolemia, smoking status, alcohol drinking habit, CKD and numbers of metabolic components, and the graded relationship existed between quartiles of WBC and incidence of MetS in both males and females.
Discussion
In this study, we found that WBC was a strong predictor for the incidence of MetS in Japanese workers. Current study showed that a graded relationship existed between quartiles of WBC and the incidence of MetS. Compared with the lowest quartile, the incidence of MetS was 1.2 to 1.6 times higher in the higher quartiles of the WBC. In addition, in participants subdivided according to smoking status, the association between quartiles of WBC and incidence of MetS was still statistically significant in never and current smokers. These data suggested that the risk for MetS defined by the modified criteria of the American Heart Association and National Heart, Lung, and Blood Institute recommendation might be estimated by stratifying the circulating WBC levels in apparently healthy workers.
A longitudinal study which addressed the relationship of WBC and the incidence of metabolic syndrome was already reported; it suggested that there are racial differences in the association between WBC and incidence of MetS (21) . We clarified that WBC was a strong predictor for the incidence of MetS in Japanese (Asian) participants. WBC is an important maker of low-grade systemic inflammation which may be a central mechanism of MetS (22) . High sensitive C-reactive protein (hs-CRP) is also a useful marker of systemic inflammation and an independent risk factor of diabetes, cardiovascular disease and MetS (23) (24) (25) . It was reported that hs-CPR is superior to WBC as an inflammatory component of MetS (23) . However, WBC is more useful than hs-CRP in clinical settings and general health check-up, because WBC is routinely measured, universally available, and the analysis price of WBC is lower than hs-CPR. The association between WBC and MetS has been demonstrated in several previous studies (14, 26, 27) . However, the biological mechanisms for these associations remain to be elucidated. Chronic inflammation which was characterized by the increased production of cytokines and acute-phase reactants and activation of inflammatory signaling network may be involved in the pathogenesis of type 2 diabetes (28, 29) . Various markers of inflammation including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and C-reactive protein, have been shown to predict the future diabetes risk, and these markers also associate with the pathogenesis of insulin resistance that is the main physiological disorder underlying MetS (11, (29) (30) (31) . It has been suggested that overnutrition and obesity through the synthesis of IL-6 and TNF-α could mediate the systemic metabolic impairment of MetS (28, 30, 32) . Furthermore, insulin resistance itself, which causes MetS, also increases the counts of inflammatory cytokines including IL-6 and TNF-α (31, 33). Thus, the subclinical inflammation and MetS might be mediated by certain inflammatory cytokines, such as TNF-α (34). These inflammatory cytokines are also known to increase the WBC (7, 35) . Several studies showed that cigarette smoking is associated with MetS (18, 36, 37) . It was also shown in previous studies that cigarette smoking increases the circulating WBC (12, 38, 39) . There was a gender difference of WBC in the current study. The prevalence of current smokers in males and females were 39.0% and 4.9% (p=0.001), and this might influence the gender difference of WBC. In the current study, the incidence of MetS in both Q3 and Q4 was significantly higher than compared to Q1 in never and current smokers, but not in former smokers. These results suggested that the low grade inflammation may play an important role in the development of MetS in both current smokers and never smokers. Quitting smoking decreases systemic inflammation and circulating WBC (1) . On the other hand, smoking cessation causes weight gain and the risk of MetS is increased after smoking cassation (37, (40) (41) (42) . Due to these contrasting effects of quitting smoking on MetS, the results of the current study in former smokers became complicated. Nevertheless, it is useful to estimate the risk for MetS in smokers as well as never smokers by stratifying WBC.
In the current study, alcohol drinking habit was significantly associated with lower WBC. In adjusted analysis, alcohol drinking habit was a decreased risk for the incidence of MetS. A similar result was reported in a previous study (43) . Modest alcohol consumption is known to suppress the production of TNF-α (44) and this might explain the finding that the alcohol drinking habit reduced the risk of MetS in the current study.
Most cross-sectional studies which investigate the relationship between WBC and prevalence of MetS were intended for the male gender (14) (15) (16) 45) . It remains unclear whether a gender difference exists in the correlation between WBC and incidence of MetS. In the current study, compared with Q1, the participants with Q4 significantly increased the risk of MetS in female gender (Table 5 ). Increasing incidence of MetS during postmenopausal period and decreasing WBC in postmenopausal woman has been shown in many studies (46, 47) . We confirmed that WBC decreases with aging in females at baseline in cross-sectional analysis (data not shown). Jeon et al reported that WBC was significantly higher in participants with MetS than those without MetS in the postmenopausal group (48) . These results indicate that WBC is a useful predictor of future MetS in females (even for the postmenopausal period) as well as in males.
The current study has several limitations. First, 42 of the 5,073 enrolled participants reported to be taking antihyperlipidemic medication. We could not specify whether such participants were taking cholesterol lowering drug(s) or TG lowering drug(s) in the current study. However, these participants were not judged to fulfill the TG criteria of MetS just because they were taking anti-hyperlipidemic drugs. Thus, it is possible that some of the individuals who were taking TG lowering drug(s) should have been categorized as not fulfilling the TG criteria. Second, self-reported information regarding alcohol intake and smoking status are frequently participants to underreporting, and misreporting could be a source of bias. Third, although age and BMI in our study sample were well in accord with those reported in a larger population-based national nutrition survey done in Japan (49), we cannot exclude the possibility that our sample contained more health-conscious people than the general population in Japan. Fourth, we did not exclude the participants with chronic inflammation diseases such as autoimmune diseases which influence WBC. We examined the association between WBC and the incidence of MetS in participants without WBC !2.5×10 9 cells/L or WBC !15.0× 10 9 cells/L for excluding the chronic inflammation diseases and hematological disorders. Adjusted hazard ratio of MetS among Q2, Q3 and Q4 were 1.21 (95% CI, 0.98 to 1.51), 1.52 (95% CI, 1.24 to 1.86), 1.66 (95% CI, 1.35 to 2.04), and the graded relationship existed between quartiles of WBC and incidence of MetS in these participants. Fifth, we did not evaluate the association of MetS and WBC subtypes. Ogawa et al showed that neutrophils are positively associated with the total cholesterol and TG levels, and inversely associated with the HDL-c level (38) . Kim et al also reported that neutrophils and lymphocytes are increased in the MetS patients (27) . However, the current study suggested that total WBC was sufficient to stratify the risk of MetS in clinical settings. Finally, since most of the participants of this study are Japanese, the generalizability of our study to non-Japanese populations is uncertain.
In conclusion, the stratification of WBC would also be useful in predicting the future development of MetS which leads to atherosclerotic diseases. It is necessary to pay further attention to the potentiality of WBC, even through the normal range, as a predictor of MetS in preventive medicine.
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